These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2561133)

  • 1. Protein-binding properties of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a synthetic analogue of 1 alpha,25-dihydroxyvitamin D3.
    Okano T; Tsugawa N; Masuda S; Takeuchi A; Kobayashi T; Nishii Y
    J Nutr Sci Vitaminol (Tokyo); 1989 Oct; 35(5):529-33. PubMed ID: 2561133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F; Mayer E; Norman AW
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biologic activity, and protein binding characteristics of a new vitamin D analog, 22-hydroxyvitamin D3.
    Gill HS; Londowski JM; Corradino R; Kumar R
    J Steroid Biochem; 1987 Aug; 28(2):147-53. PubMed ID: 3041108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis and biological activity of 25-hydroxy-26,27-dimethylvitamin D3 and 1,25-dihydroxy-26,27-dimethylvitamin D3: highly potent novel analogs of vitamin D3.
    Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
    J Steroid Biochem; 1988 Aug; 31(2):147-60. PubMed ID: 3404985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding properties, with blood proteins, and tissue distribution of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a noncalcemic analogue of 1 alpha, 25-dihydroxyvitamin D3, in rats.
    Kobayashi T; Tsugawa N; Okano T; Masuda S; Takeuchi A; Kubodera N; Nishii Y
    J Biochem; 1994 Mar; 115(3):373-80. PubMed ID: 8056745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N; Dutta A; Ray R
    Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism.
    Okano T; Tsugawa N; Masuda S; Takeuchi A; Kobayashi T; Takita Y; Nishii Y
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1444-9. PubMed ID: 2551289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the specificity of vitamin D compounds binding to chick pig intestinal 1,25-dihydroxyvitamin D3 receptor.
    Link RP; DeLuca HF
    Steroids; 1988; 51(5-6):583-98. PubMed ID: 2853890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of novel vitamin D analogues: 24,24-difluoro-25-hydroxy-26,27-dimethylvitamin D3 and 24,24-difluoro-1 alpha,25-dihydroxy-26,27-dimethylvitamin D3.
    Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
    J Med Chem; 1990 Feb; 33(2):480-90. PubMed ID: 2153815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of 24R,25-dihydroxyvitamin D3 to chick intestinal mucosa: 24R,25-dihydroxyvitamin D3 is an allosteric effector of 1,25-dihydroxyvitamin D3 binding.
    Wilhelm F; Ross FP; Norman AW
    Arch Biochem Biophys; 1986 Aug; 249(1):88-94. PubMed ID: 3017223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and binding properties of 24,24-difluoro-25-hydroxyvitamin D3.
    Tanaka Y; Wichmann JK; De Luca HF; Kobayashi Y; Ikekawa N
    Arch Biochem Biophys; 1983 Sep; 225(2):649-55. PubMed ID: 6688712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor.
    Addo JK; Swamy N; Ray R
    Steroids; 1999 Apr; 64(4):273-82. PubMed ID: 10399884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 25-hydroxy-[26,27-3H]vitamin D2, 1,25-dihydroxy-[26,27-3H]vitamin D2 and their (24R)-epimers.
    Sicinski RR; Tanaka Y; Phelps M; Schnoes HK; DeLuca HF
    Anal Biochem; 1987 Feb; 161(1):96-102. PubMed ID: 3495200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.
    Bishop JE; Collins ED; Okamura WH; Norman AW
    J Bone Miner Res; 1994 Aug; 9(8):1277-88. PubMed ID: 7976510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
    J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surface plasmon resonance in the binding study of vitamin D, metabolites and analogues with vitamin D binding protein.
    Canoa P; Rivadulla ML; Popplewell J; van Oosten R; Gómez G; Fall Y
    Anal Bioanal Chem; 2017 Apr; 409(10):2547-2558. PubMed ID: 28116494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic analogue of vitamin D3, 22-oxa-1,25-dihydroxy-vitamin D3, stimulates the production of prostacyclin by vascular tissues.
    Inoue M; Wakasugi M; Wakao R; Gan N; Tawata M; Nishii Y; Onaya T
    Life Sci; 1992; 51(14):1105-12. PubMed ID: 1518373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
    Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding properties of plasma vitamin D-binding protein and intestinal 1,25-dihydroxyvitamin D3 receptor in piglets with pseudo-vitamin D-deficiency rickets, type I: treatment effects with pharmacological doses of vitamin D3.
    Kaune R; Schroeder B; Harmeyer J
    Arch Biochem Biophys; 1990 Nov; 282(2):326-32. PubMed ID: 2173481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.